Trial Profile
Lisdexamphetamine treatment of Bulimia Nervosa with and without probable simultaneous Attention Deficit Hyperactivity Disorder (ADHD). A randomized , open, fase II-study with cross-over design. Lisdexamfetaminbehandling vid Bulimia Nervosa med och utan samtidig sannolik Attention Deficit Hyperactivity Disorder (ADHD). En randomiserad, öppen, fas II- studie med cross-over design.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 25 Oct 2018
Price :
$35
*
At a glance
- Drugs Lisdexamfetamine (Primary)
- Indications Attention-deficit hyperactivity disorder; Eating disorders; Mood disorders
- Focus Therapeutic Use
- 25 Oct 2018 New trial record